Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,520 | 110 | 97.2% |
| Education | $43.30 | 5 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $264.55 | 20 | $0 (2019) |
| PFIZER INC. | $250.72 | 20 | $0 (2019) |
| GlaxoSmithKline, LLC. | $168.24 | 14 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $167.25 | 11 | $0 (2018) |
| Novo Nordisk Inc | $136.59 | 9 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $117.56 | 8 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $71.72 | 6 | $0 (2018) |
| Lilly USA, LLC | $63.76 | 4 | $0 (2018) |
| Amgen Inc. | $57.16 | 4 | $0 (2018) |
| MannKind Corporation | $49.40 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $79.02 | 5 | AstraZeneca Pharmaceuticals LP ($63.99) |
| 2018 | $701.67 | 51 | PFIZER INC. ($167.57) |
| 2017 | $782.65 | 59 | SANOFI-AVENTIS U.S. LLC ($146.40) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/20/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/15/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/09/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/14/2019 | PFIZER INC. | CHANTIX (Drug) | Education | In-kind items and services | $15.03 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 12/10/2018 | PFIZER INC. | COLOGUARD (Device) | Education | In-kind items and services | $4.69 | General |
| Category: GASTROINTESTINAL | ||||||
| 10/16/2018 | PFIZER INC. | COLOGUARD (Device) | Education | In-kind items and services | $4.69 | General |
| Category: GASTROINTESTINAL | ||||||
| 09/26/2018 | PFIZER INC. | LYRICA (Drug), EUCRISA | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 09/24/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: UROLOGY | ||||||
| 09/19/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/12/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Diabetes | ||||||
| 09/10/2018 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE, BASAGLAR | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Diabetes | ||||||
| 08/29/2018 | Allergan Inc. | LINZESS (Drug), VIBERZI | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/27/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE, GLYXAMBI | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: DIABETES | ||||||
| 08/22/2018 | GlaxoSmithKline, LLC. | BREO (Drug), ADVAIR | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/20/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/13/2018 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: VACCINES | ||||||
| 08/06/2018 | PFIZER INC. | CHANTIX (Drug), LYRICA, EUCRISA | Food and Beverage | In-kind items and services | $12.60 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/30/2018 | Allergan Inc. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $13.36 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/25/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: RESPIRATORY | ||||||
| 07/18/2018 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $9.59 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 07/16/2018 | Takeda Pharmaceuticals U.S.A., Inc. | Amitiza (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Lower GI | ||||||
| 07/11/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/09/2018 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 626 | 919 | $206,645 | $63,271 |
| 2022 | 6 | 666 | 952 | $180,629 | $63,798 |
| 2021 | 4 | 671 | 956 | $178,492 | $68,905 |
| 2020 | 8 | 739 | 966 | $180,831 | $58,967 |
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 235 | 446 | $95,747 | $26,962 | 28.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 203 | 203 | $70,252 | $25,306 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 161 | 243 | $35,394 | $9,419 | 26.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $4,196 | $1,510 | 36.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 15 | 15 | $1,056 | $75.12 | 7.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 222 | 222 | $59,634 | $27,963 | 46.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 239 | 450 | $85,484 | $25,833 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 130 | 201 | $26,017 | $7,306 | 28.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 14 | 14 | $5,326 | $1,836 | 34.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 30 | $1,819 | $678.89 | 37.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2022 | 34 | 35 | $2,349 | $182.40 | 7.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 246 | 246 | $63,482 | $31,424 | 49.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 288 | 523 | $93,695 | $30,517 | 32.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 114 | 163 | $19,774 | $6,828 | 34.5% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2021 | 23 | 24 | $1,540 | $135.66 | 8.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 224 | 224 | $55,728 | $25,402 | 45.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 297 | 480 | $88,719 | $23,263 | 26.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 128 | 169 | $19,754 | $5,037 | 25.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 15 | 15 | $5,588 | $2,519 | 45.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2020 | 14 | 14 | $4,996 | $1,638 | 32.8% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 22 | 25 | $3,183 | $740.62 | 23.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 18 | 18 | $1,553 | $247.11 | 15.9% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Office | 2020 | 21 | 21 | $1,310 | $120.70 | 9.2% |
About Dr. Joseph Mathew, M.D
Dr. Joseph Mathew, M.D is a Internal Medicine healthcare provider based in Racine, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023031853.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Mathew, M.D has received a total of $1,563 in payments from pharmaceutical and medical device companies, with $79.02 received in 2019. These payments were reported across 115 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,520).
As a Medicare-enrolled provider, Mathew has provided services to 2,702 Medicare beneficiaries, totaling 3,793 services with total Medicare billing of $254,941. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Racine, WI
- Active Since 07/25/2006
- Last Updated 07/08/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1023031853
Products in Payments
- FARXIGA (Drug) $161.49
- CHANTIX (Drug) $108.83
- SOLIQUA (Drug) $107.16
- BEVESPI AEROSPHERE (Drug) $78.27
- ADVAIR (Drug) $57.63
- JARDIANCE (Drug) $55.82
- TRADJENTA (Drug) $52.79
- Victoza (Drug) $51.09
- AFREZZA (Drug) $49.40
- JANUVIA (Drug) $49.21
- Trulance (Drug) $48.65
- BREO (Drug) $47.19
- ANORO (Drug) $43.24
- PREVNAR - 13 (Biological) $42.15
- Prolia (Biological) $41.94
- XIFAXAN (Drug) $39.51
- ELIQUIS (Drug) $32.86
- TOUJEO (Drug) $32.17
- TRULICITY (Drug) $31.08
- LYRICA (Drug) $30.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Racine
Kaye-Eileen Willard, Md, MD
Internal Medicine — Payments: $114,467
Gregory Culen, M.d, M.D
Internal Medicine — Payments: $5,142
Gerald Wisniewski, Md, MD
Internal Medicine — Payments: $4,673
Paul Durbin, M.d, M.D
Internal Medicine — Payments: $3,033
Dr. Michael Papp, D.o, D.O
Internal Medicine — Payments: $2,141
Dr. Roger Boye, Md, MD
Internal Medicine — Payments: $1,595